Overall, the TNF-α/IGF2BP3/CLDN11 axis was involved in the mechanism of obesity-mediated SAP exacerbation and suggests potential therapeutic targets. Here, IGF2BP3 is linked to obesity due to melanocortin 4 receptor deficiency.